AbbVie links up with Johns Hopkins University in cancer research
December 7, 2016Medical Communications
AbbVie has announced that it has agreed a five-year collaboration agreement with Johns Hopkins University. The aim of the collaboration …
AstraZeneca’s Lisa Anson appointed president of ABPI
December 7, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Lisa Anson, current president of AstraZeneca UK & Ireland, has been appointed to the position of president of ABPI. Lisa …
Janssen reveals positive results from longest follow-up of Imbruvica
December 7, 2016Research and Development AbbVie, Cilag, Janssen, Pharmacyclics, imbruvica
Janssen used the 5th Annual American Society of Hematoly Meeting and Exposition to reveal that a five-year study of Imbruvica …
Novo pledges single-digit cap on drug price hikes
December 7, 2016Medical Communications, Research and Development, Sales and Marketing Jakob Riis, Novo Nordisk
Novo Nordisk US chief Jakob Riis (pictured) has announced the insulin giant’s commitment to limit its price increases to single-digit …
Pfizer slapped with record £84.2 million fine for 2,600% price increase
December 7, 2016Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine
Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …
AZ lung cancer drug cuts disease progression by 70%
December 7, 2016Research and Development AstraZeneca, Tagrisso
AstraZeneca is touting its cancer drug Tagrisso (osimertinib) as a potential new standard of care for epidermal growth factor receptor …
Veeva releases key details from European Life Sciences Survey
December 6, 2016veeva
Veeva, which held its European Life Sciences Summit last week, has announced some of the key findings from its European …
Shire given permission for $400 million biologics manufacturing facility
December 6, 2016Manufacturing and Production, Research and Development Co Meat, Ireland, Shire
Shire has received planning permission for a new state-of-the-art biologics manufacturing facility in Co Meath, Ireland. The plant will be …
CMO of OncoMed Pharma resigns
December 6, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
OncoMed Pharmaceuticals, a clinical-stage pharmaceutical company, announced that Jakob Dupont has resigned from his positions as the company’s senior vice …
CEO of Teva’s Generics Medicines Group steps down
December 6, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva
Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …
Cannabis-based treatment scores Phase 3 successes for GW Pharma
December 6, 2016Manufacturing and Production, Research and Development GW Pharma, cannabidiol
UK-based GW Pharmaceuticals, a biopharmaceutical firm focused on the development of novel cannabinoid therapies, has unveiled new efficacy data for …
CEO of Teva’s Generics Medicines Group steps down
December 6, 2016Manufacturing and Production, Medical Communications Teva, generics
Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …
Xenetic Biosciences promote Jeffrey Eisenberg from board member to COO
December 5, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Xenetic
Xenetic Biosciences, a clinical-stage biopharmaceutical company, has announced the appointment of Jeffrey Eisenberg as chief operating officer. Mr. Eisenberg has …
Merck and Roche extend distribution ties
December 5, 2016Manufacturing and Production Merck, Roche, distribution
Merck KGaA and Roche have announced that they will further increase the distribution links between the two companies by having …
Takeda to invest €40m in Dublin operations expansion
December 5, 2016Manufacturing and Production Dublin, Ireland, Nanlarotm, Takeda
Takeda has announced it is to invest $40 million in a new facility in Dublin, adding a new facility and …
Mission Therapeutics announces new non-executive chairman
December 5, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mission Therapeutics, appointment
Drug discovery and development firm Mission Therapeutics has announced that it has appointed Dr Colin Goddard (pictured) as non-executive chairman …
Scientists create ‘map of drugs’ to aid further development
December 5, 2016Manufacturing and Production, Medical Communications
Researchers at The Institute of Cancer Research have used drugs licensed through the FDA to create a map of all …
Veeva announces Veeva CRM Engage Meeting at European Commercial Summit
December 5, 2016Medical Communications Big Data, CRM, veeva
Veeva, a cloud software company, concluded its annual European Commercial Summit last week, held this year in Madrid. The conference …
FDA approves another indication for Lilly/Boehringer diabetes treatment
December 5, 2016Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, jardiance
Jardiance (empagliflozin), an oral SGLT02 inhibitor developed by Eli Lilly and distributed by Boehringer Ingelheim, has been approved by the …
Technology and patient adherence: Putting control of medication directly in patients’ hands
December 5, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing apps, patient adherence, technology
Ben Hargreaves looks at how apps and medical devices could reduce these figures by providing patients new ways of keeping …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
